Pulmozime
Ask a doctor about a prescription for Pulmozime
How to use Pulmozime
Pulmozyme
1 mg/ml, for nebulization
nebulization
2500 U/2.5 ml
Dornase alfa
- .
- harm
- or pharmacist. See section 4.
Spi
:
- 1. What is Pulmozyme and what is it used for
- 2. Important information before using Pulmozyme
- 3. Pulmozyme
- 4.
- 5. How to store Pulmozyme
- 6. Undesirable effects
1.
Pulmozyme contains
de
1
cut
out
Dornase alfa produced by
genetic engineering.
Pulmozyme
Drug Pul
Drug
in the form of a solution for inhalation with a nebulizer (see section 3. How
.
2.
using Pulmozyme
When not to use Pulmozyme
I
patient has an allergy (
or
to this drug (listed in section 6).
do not use Pulmozyme
.
Children
u
limited.
Pulmozyme in children under the age of
years
, and therapy
conducted
Pulmozyme and other medicines
tell your doctor or pharmacist about all medicines the patient is taking
,
including standard medicines used in cystic fibrosis,
and
,
Before using any medicine, consult your doctor or pharmacist.
N
when using dornase alfa in women.
operating machinery
Drug
on
operating
machinery.
3.
always
In case of
consult your doctor or pharmacist.
The recommended dose is 2500 U (2.5 mg) of dornase alfa in the form of inhalation once
. Inhalations
ml of solution)
using a recommended nebulizer.
in children under the age of
years
when using Pulmozyme
twice a day
.
during regular, daily
use of Pulmozyme. Studies,
,
about the reason
for
Pulmozyme m
So far, no
,
Pulmozyme should not be mixed with other medicines or solutions in the nebulizer chamber. Mixing Pulmozyme with other
medicines.
using
a nebulizer chamber, such as:
Hudson T Up-draft II/Pulmo-Aide, Airlife Misty/Pulmo-Aide, Respirgard/Pulmo-Aide or
Acorn II/Pulmo-Aide.
,
such as Pari LL/Inhalierboy, Pari LC/Inhalierboy or Master, Pari Baby, Aiolos/2 Aiolos, Side
Stream/CR50 or MobilAire or Porta-Neb.
nebulizer Pari eRAPID
.
nebulizer
ies, because
Pulmozyme
Pulmozyme.
Administering the drug
rules:
.
any unused Pulmozyme from the previous inhalation. All unused
according to the information contained in
section 5.
after their
consult your doctor.
.
O
.
.
nebulizer.
drug
.
Using the dose of Pulmozyme
l
Method of administration of Pulmozyme
Discontinuation of Pulmozyme
In case of discontinuation
discontinuation of Pulmozyme.
inform your doctor or pharmacist.
4.
this drug
,
.
clinical trials, as well as after the introduction of Pulmozyme to the market, used in recommended doses.
drug
in less than 1 in
1000
)
z
,
hoarseness,
laryngitis,
nasal congestion (runny nose),
worsening
,
n
,
rash, urticaria,
b
changes in Pulmozyme dosing.
drug
Pulmozyme.
.
5 in 100
allergic to dornase alfa.
Improvement in tests for
dornase alfa.
In a study conducted in children aged
children aged 5 to 10 years.
any of the following
not listed in
inform your doctor or pharmacist.
in
:
Department of
ation
Al. Jerozolimskie 181C
02 222 Warsaw
Phone: + 48 22 49 21 301
Fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
to the person responsible.
5. Pulmozyme
.
foil bags, in the original packaging
to protect against
.
Single
drug.
Pulmozyme after
expiration date
stated on the packaging.
after
,
6.
What Pulmozyme contains
- is dornase alfa (phosphorylated and glycosylated, recombinant). It contains 2500 U (2.5 mg) of dornase alfa in 2.5 ml of solution. U/ml (1 mg/ml, 1 Genentech unit/ml = 1 g/ml).
- In addition, the drug contains: sodium chloride, calcium chloride dihydrate, water.
Drug
in the form of a solution for inhalation with a nebulizer.
ach
is clear and colorless
.
Packaging contains
Marketing Authorization Holder and Importer
Marketing Authorization Holder:
Roche Polska Sp. z o.o.
ul. Domaniewska 28
02-672 Warsaw, Poland
Phone: +48 22 345 1888
Fax: +48 22 345 1874
Importer:
Roche Pharma AG
Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany
Date of last revision of the leaflet:
Pulmozyme
1 mg/ml, for nebulization
2500 U/2.5 ml
Dornase alfa
- .
- harm
- or pharmacist. See section 4.
Spi
:
- 1. What is Pulmozyme and what is it used for
- 2. Important information before using Pulmozyme
- 3. Pulmozyme
- 4.
- 5. How to store Pulmozyme
- 6. Undesirable effects
1.
Pulmozyme contains
de
1
cut
out
Dornase alfa produced by
genetic engineering.
Pulmozyme
Drug Pul
Drug
in the form of a solution for inhalation with a nebulizer (see section 3. How
.
2.
using Pulmozyme
When not to use Pulmozyme
I
patient has an allergy (
or
to this drug (listed in section 6).
do not use Pulmozyme
.
Children
u
limited.
Pulmozyme in children under the age of
years
, and therapy
conducted
Pulmozyme and other medicines
tell your doctor or pharmacist about all medicines the patient is taking
,
including standard medicines used in cystic fibrosis,
and
,
Before using any medicine, consult your doctor or pharmacist.
N
when using dornase alfa in women.
operating machinery
Drug
on
operating
machinery.
3.
always
In case of
consult your doctor or pharmacist.
The recommended dose is 2500 U (2.5 mg) of dornase alfa in the form of inhalation once
. Inhalations
ml of solution)
using a recommended nebulizer.
in children under the age of
years
when using Pulmozyme
twice a day
.
during regular, daily
use of Pulmozyme. Studies,
,
about the reason
for
Pulmozyme m
So far, no
,
Pulmozyme should not be mixed with other medicines or solutions in the nebulizer chamber. Mixing Pulmozyme with other
medicines.
using
a nebulizer chamber, such as:
Hudson T Up-draft II/Pulmo-Aide, Airlife Misty/Pulmo-Aide, Respirgard/Pulmo-Aide or
Acorn II/Pulmo-Aide.
,
such as Pari LL/Inhalierboy, Pari LC/Inhalierboy or Master, Pari Baby, Aiolos/2 Aiolos, Side
Stream/CR50 or MobilAire or Porta-Neb.
nebulizer Pari eRAPID
.
nebulizer
ies, because
Pulmozyme
Pulmozyme.
Administering the drug
rules:
.
any unused Pulmozyme from the previous inhalation. All unused
according to the information contained in
section 5.
after their
consult your doctor.
.
O
.
.
nebulizer.
drug
.
Using the dose of Pulmozyme
l
Method of administration of Pulmozyme
Discontinuation of Pulmozyme
In case of discontinuation
discontinuation of Pulmozyme.
inform your doctor or pharmacist.
4.
this drug
,
.
clinical trials, as well as after the introduction of Pulmozyme to the market, used in recommended doses.
drug
in less than 1 in
1000
)
z
,
hoarseness,
laryngitis,
nasal congestion (runny nose),
worsening
,
n
,
rash, urticaria,
b
changes in Pulmozyme dosing.
drug
Pulmozyme.
.
5 in 100
allergic to dornase alfa.
Improvement in tests for
dornase alfa.
In a study conducted in children aged
children aged 5 to 10 years.
any of the following
not listed in
inform your doctor or pharmacist.
in
:
Department of
ation
Al. Jerozolimskie 181C
02 222 Warsaw
Phone: + 48 22 49 21 301
Fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
to the person responsible.
5. Pulmozyme
.
foil bags, in the original packaging
to protect against
.
Single
drug.
Pulmozyme after
expiration date
stated on the packaging.
after
,
6.
What Pulmozyme contains
- is dornase alfa (phosphorylated and glycosylated, recombinant). It contains 2500 U (2.5 mg) of dornase alfa in 2.5 ml of solution. U/ml (1 mg/ml, 1 Genentech unit/ml = 1 g/ml).
- In addition, the drug contains: sodium chloride, calcium chloride dihydrate, water.
Drug
in the form of a solution for inhalation with a nebulizer.
ach
is clear and colorless
.
Packaging contains
Marketing Authorization Holder and Importer
Marketing Authorization Holder:
Roche Polska Sp. z o.o.
ul. Domaniewska 28
02-672 Warsaw, Poland
Phone: +48 22 345 1888
Fax: +48 22 345 1874
Importer:
Roche Pharma AG
Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany
Date of last revision of the leaflet:
- Country of registration
- Active substance
- Prescription requiredYes
- ImporterRoche Pharma AG
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to PulmozimeDosage form: Solution, 20 mg/mlActive substance: acetylcysteinePrescription not requiredDosage form: Tablets, 100 mgActive substance: acetylcysteinePrescription not requiredDosage form: Powder, 100 mg/sachetActive substance: acetylcysteineManufacturer: Salutas Pharma GmbHPrescription not required
Alternatives to Pulmozime in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to Pulmozime in Ucrania
Alternative to Pulmozime in España
Online doctors for Pulmozime
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Pulmozime – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
